Press Releases

Peruse Health Union’s latest news announcements on survey findings, awards, leadership, and more. News media interested in learning more about how Health Union can help them tell the health stories they want to tell can visit our Press Kit and Resource Center for News Media.

Health Union Unveils New DTC Media & Marketing Solutions

October 14, 2024

Health Union’s latest innovations will capitalize on the company’s industry-leading network of real patient leaders, unparalleled content capabilities, and differentiated first-party data to drive improved audience quality, efficiencies, and conversions for pharmaceutical advertising partners.

Bladder Cancer In America Survey Shows Remission Correlates With Multiple Factors Beyond Treatment Itself

October 17, 2018

Survey results from Bladder Cancer In America 2018, Health Union LLC’s national survey of 401 respondents conducted among both patients and care partners impacted by the condition, show that for people in remission, a number of factors beyond the treatment itself contributed to reporting good experiences with bladder cancer.

Survey Finds Early Endometriosis Diagnosis After Initial Symptoms Improves Treatment Approach, Quality of Life

October 2, 2018

Results from Endometriosis In America 2018, a national survey by Health Union, LLC of people impacted by the condition, contribute to the notion that an early diagnosis after initial symptoms are experienced can help to improve quality of life and provide greater awareness of symptoms.

Health Union Acknowledged by Inc. 5000 as One of the Fastest-Growing Companies in the U.S.

August 15, 2018

Inc. magazine announced that Health Union has been ranked No. 740 on the 37th annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. After steadily receiving awards and recognitions within the Philadelphia business community and life sciences industry over the past eight years, the Inc. 5000 represents Health Union’s first national recognition.

Survey Finds Migraine Patients Largely Unaware of Newly Available CGRP Medications

August 9, 2018

People living with migraine recently gained another significant tool to effectively manage their condition when the U.S. Food and Drug Administration approved the first treatment to target calcitonin-gene-related peptides (CGRP). However, only one-third of respondents of Migraine In America 2018, a national survey by Health Union, LLC of people impacted by the condition, are even aware of CGRP therapies.

Press Releases

Health Union Unveils New DTC Media & Marketing Solutions

Bladder Cancer In America Survey Shows Remission Correlates With Multiple Factors Beyond Treatment Itself

Survey Finds Early Endometriosis Diagnosis After Initial Symptoms Improves Treatment Approach, Quality of Life

Health Union Acknowledged by Inc. 5000 as One of the Fastest-Growing Companies in the U.S.

Survey Finds Migraine Patients Largely Unaware of Newly Available CGRP Medications

Health Union Launches Online Community for Opioid Use Disorder

Health Union Earns 12 Digital Health Awards for Excellence in Patient Education and Support

Health Launches Online Health Communities in Mental Health and Cardiometabolic Conditions

Health Union Presents 2024 Findings in Distinguished “In America”

Contact